Zepbound® and heartburn

Two rows, two kinds of burning

NIDDK describes indigestion as pain, burning or discomfort in the upper abdomen, often with feeling full too soon, or too full after a small meal, plus bloating, nausea or belching; it stresses that heartburn and indigestion are separate conditions even when they turn up together. ^[6] Cleveland Clinic draws the line by place: burning felt in the chest is heartburn, burning nearer the stomach is indigestion. ^[8] Zepbound®’s US label follows the same split, counting dyspepsia and gastroesophageal reflux disease (GERD) as separate rows. ^[1]

The rates come from SURMOUNT-1 and SURMOUNT-2, 72-week placebo-controlled trials in 2,519 adults on Zepbound®; the 5 mg column rests on SURMOUNT-1 alone. ^[1][3] There is no Zepbound® authorisation in the European Union; the European information covers tirzepatide as Mounjaro® and rates both reactions as common. ^[4]

What the pattern across doses shows

Indigestion was reported roughly twice as often as reflux at every dose, and each was about double its placebo rate. ^[1] Neither climbed neatly with dose; in Canada’s figures reflux was lowest at 10 mg. ^[3] A person could report both, so the two rows cannot be added into one heartburn figure. The label gives no timing or stopping rate for either row: its statement that symptoms clustered during dose increases names nausea, vomiting and diarrhea only. ^[1] For the sleep apnoea trials, at 10 or 15 mg, it says reactions resembled the weight trials and prints no separate reflux figure. ^[1]

Why the burning may come: three layers

• Supported by the label. Tirzepatide slows stomach emptying; the effect is largest after the first dose, was clearest after a single 5 mg dose and shrinks with later doses. ^[1] Both reflux and indigestion were more frequent than on placebo. ^[1] NIDDK independently lists GLP-1 receptor agonists among medicines that can bring on indigestion. ^[6]
• Plausible, not measured. Cleveland Clinic explains that lying down after a large meal can briefly relax the valve at the lower end of the food pipe, and that heavy, fatty meals take longer to digest and may not have cleared by bedtime. ^[8] A stomach that empties more slowly could stretch that window, but no Zepbound® study in these sources has measured reflux against meal timing.
• General background. NIDDK says doctors often cannot pin down why indigestion happens; research points to factors such as how well the stomach relaxes and stretches with food, a sensitive upper small intestine, and anxiety or depression. ^[6]

Causes that were there before the first injection

Cleveland Clinic lists obesity among the main risk factors for reflux, because extra pressure inside the abdomen and hormones from fat tissue can weaken that valve; hiatal hernia, pregnancy and smoking are the others it names. ^[8] Some medicines relax the valve too, including anti-inflammatory painkillers (NSAIDs), calcium channel blockers, some antidepressants and theophylline. ^[8]

For indigestion, NIDDK adds certain antibiotics, NSAIDs, iron supplements, medicines for osteoporosis and steroids, as well as peptic ulcers and infections such as H. pylori. ^[6] Cleveland Clinic names chocolate, coffee, alcohol, mint, garlic and onions as foods that can relax the valve in larger amounts. ^[8] If another medicine started around the same time as Zepbound®, mention both to your prescriber.

What general sources say may help

• Everyday measures from Cleveland Clinic: smaller meals, eating a few hours before you lie down, raising the head of the bed with pillows or a foam wedge, cutting back on trigger foods and alcohol, not smoking and avoiding tight clothing. ^[8]
• During an episode it suggests standing up, taking small sips of water, loosening a belt or waistband, or taking an antacid. ^[8]
• NIDDK notes that H2 blockers and proton pump inhibitors are sold without a prescription, that indigestion which does not improve needs a doctor, and that supplements should be checked with your doctor first. ^[7]
• Zepbound® can change how tablets are absorbed, and the Medication Guide asks you to tell your provider about every medicine you take, including over-the-counter ones; ask your pharmacist before adding an acid reducer. ^[1][2]
• When a medicine is the cause, NIDDK says your doctor may suggest changes to what you take. ^[7] With Zepbound®, that call belongs to your prescriber.

A reporting study that seems to contradict the label

A 2025 study of the FDA Adverse Event Reporting System examined 25,212 tirzepatide reports from mid-2022 to the end of 2023. Reflux was reported more often than expected (191 reports, reporting odds ratio 3.24), and the authors described reflux and burping as adverse events not previously reported. ^[5] Yet the current US label lists both in Table 1. ^[1] The abstract does not say which label version or definitions the authors compared against, so “new” describes that study’s comparison, not today’s label.

The same analysis found that men reported more digestive problems and women more injection-site reactions. ^[5] Reporting databases cannot give a rate or prove that the medicine caused a given case; they show which reports stand out.

When chest burning is not a heartburn question

Cleveland Clinic explains that pain from the food pipe can feel like heavy pressure or tightness in the chest, because it travels along the same nerves as pain from the heart. ^[8] That overlap is why NIDDK asks anyone with indigestion plus pain in the chest, jaw, neck or arm, or shortness of breath, to see a doctor right away rather than treat it at home. ^[6]

Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.